Effector Therapeutics Inc (EFTR)

$0.00 0.00 (N/A)
Market Cap 1,000.00
Revenue (ttm) 0.00
Net Income (ttm) -35.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 22.80
Volume 5,300
Avg Vol 3,410
Day's Range N/A - N/A
Shares Out 4.70M
Stochastic %K 11%
Beta 0.22
Analysts Strong Buy
Price Target $10.00

Company Profile

eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. The company's lead product candidates comprise Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer; and Zotatifin, a small molecule inhibitor of eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 925 8215
Address:
142 North Cedros Avenue, Suite B, Solana Beach, United States
11thestate
11thestate May. 30 at 1:20 PM
$EFTR stockholders filed a claim against eFFECTOR Therapeutics for allegedly misleading investors ahead of its 2024 stock offering and abruptly announcing a full wind-down months later. You can join this case to be notified about any new information: https://11th.com/cases/effector-investor-case
0 · Reply
11thestate
11thestate May. 15 at 12:08 PM
$EFTR stockholders filed a claim against eFFECTOR Therapeutics for misleading them about its clinical progress, financial stability, and future operations ahead of its 2024 stock offering. You can join this case to be notified about potential recovery: https://11th.com/cases/effector-investor-case
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 26 at 5:29 PM
$EFTR Zotatifin looking promising in breast cancer trials. Watching closely for next clinical updates. Might nibble on small position if more positive data comes out. strong article: https://beyondspx.com/article/effector-therapeutics-inc-eftr-pioneering-a-new-class-of-oncology-drugs
0 · Reply
atreus57
atreus57 Jan. 28 at 3:55 PM
$LXRX overall good news... stable growth, should enter a phase of rapid sustainable growth... $IBRX $EFTR $GRTX seems like $LXRX will grow soon and will have profitability soon... very good job!
0 · Reply
zawojak
zawojak Dec. 30 at 9:21 PM
$ATXI this company is dead, they will wind down the business like $EFTR has done. Mote likely say goodbye to your bags. SCAM
0 · Reply
Smarty22
Smarty22 Dec. 22 at 3:25 PM
$EFTR why even this is active? Is there still any hope to have some company buy their research and continue it? Anyone?
0 · Reply
zawojak
zawojak Nov. 2 at 2:45 PM
$UNCY So in the next two weeks, either positive news and stock goes over $1 and stays there, or bad news then possibly it will drop to $0.30 and Mr Gupta will ask NASDAQ for extension or Mr Gupta will kick off RS split and we are all cooked and loosers bag holders. 3:1 chances of making money here. I am bullish but was bullish with $EFTR and lost 90%. 💩
1 · Reply
zawojak
zawojak Oct. 23 at 2:40 PM
$SLS I can sense another $EFTR here guys, be careful 📉
2 · Reply
NextNeighbour
NextNeighbour Oct. 7 at 8:37 PM
$EFTR what’s happening with this stock.Whats news? Anyone can you pls share?
0 · Reply
Capitulation_0
Capitulation_0 Oct. 1 at 2:25 PM
$EFTR Sad to see this one die. CEO not too long ago said he has never seen the excitement around his compound in 20 years. He came from big pharma and I suspect people believed him and didn't think he was some sort of snake oil salesman.
0 · Reply
Latest News on EFTR
No data available.
11thestate
11thestate May. 30 at 1:20 PM
$EFTR stockholders filed a claim against eFFECTOR Therapeutics for allegedly misleading investors ahead of its 2024 stock offering and abruptly announcing a full wind-down months later. You can join this case to be notified about any new information: https://11th.com/cases/effector-investor-case
0 · Reply
11thestate
11thestate May. 15 at 12:08 PM
$EFTR stockholders filed a claim against eFFECTOR Therapeutics for misleading them about its clinical progress, financial stability, and future operations ahead of its 2024 stock offering. You can join this case to be notified about potential recovery: https://11th.com/cases/effector-investor-case
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 26 at 5:29 PM
$EFTR Zotatifin looking promising in breast cancer trials. Watching closely for next clinical updates. Might nibble on small position if more positive data comes out. strong article: https://beyondspx.com/article/effector-therapeutics-inc-eftr-pioneering-a-new-class-of-oncology-drugs
0 · Reply
atreus57
atreus57 Jan. 28 at 3:55 PM
$LXRX overall good news... stable growth, should enter a phase of rapid sustainable growth... $IBRX $EFTR $GRTX seems like $LXRX will grow soon and will have profitability soon... very good job!
0 · Reply
zawojak
zawojak Dec. 30 at 9:21 PM
$ATXI this company is dead, they will wind down the business like $EFTR has done. Mote likely say goodbye to your bags. SCAM
0 · Reply
Smarty22
Smarty22 Dec. 22 at 3:25 PM
$EFTR why even this is active? Is there still any hope to have some company buy their research and continue it? Anyone?
0 · Reply
zawojak
zawojak Nov. 2 at 2:45 PM
$UNCY So in the next two weeks, either positive news and stock goes over $1 and stays there, or bad news then possibly it will drop to $0.30 and Mr Gupta will ask NASDAQ for extension or Mr Gupta will kick off RS split and we are all cooked and loosers bag holders. 3:1 chances of making money here. I am bullish but was bullish with $EFTR and lost 90%. 💩
1 · Reply
zawojak
zawojak Oct. 23 at 2:40 PM
$SLS I can sense another $EFTR here guys, be careful 📉
2 · Reply
NextNeighbour
NextNeighbour Oct. 7 at 8:37 PM
$EFTR what’s happening with this stock.Whats news? Anyone can you pls share?
0 · Reply
Capitulation_0
Capitulation_0 Oct. 1 at 2:25 PM
$EFTR Sad to see this one die. CEO not too long ago said he has never seen the excitement around his compound in 20 years. He came from big pharma and I suspect people believed him and didn't think he was some sort of snake oil salesman.
0 · Reply
GhostAlphaTrading
GhostAlphaTrading Sep. 29 at 7:19 PM
$EFTR I love comming around when things get spicy 👀
0 · Reply
zawojak
zawojak Sep. 4 at 12:57 PM
$UNCY Seems like I made mistake again, stock reminds me of $EFTR. Management may announce something shitty soon and we will get $0.03 SP. It just doesn't sound right. CEO doesn't keep shareholders updated with anything. BTW when should we expect NDA to be approved? Are there any upcoming catalysts ???
5 · Reply
zawojak
zawojak Jul. 30 at 1:56 PM
$SLS Don't be $EFTR
0 · Reply
zawojak
zawojak Jul. 30 at 10:26 AM
$ATXI may follow $EFTR :\
1 · Reply
Fearless_Contrarian
Fearless_Contrarian Jul. 29 at 8:59 PM
$EFTR I’m down 99% on this. But, I can I lose, if I don’t sell 😂 ? Thankfully it is tiny portion of my portfolio.
1 · Reply
zawojak
zawojak Jul. 29 at 12:35 PM
$ATXI May go to administration like $EFTR
0 · Reply
Fearless_Contrarian
Fearless_Contrarian Jul. 26 at 1:37 PM
$EFTR This is the worst speculative stock investment I ever made. I’m down 99% 😂 Thankfully , it was tiny % of my portfolio
0 · Reply
Kikic
Kikic Jul. 25 at 10:54 PM
$EFTR ops 🤙
0 · Reply